Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Gulnara Abdilova"'
Autor:
Indira Jaxybayeva, Riza Boranbayeva, Sagira Abdrakhmanova, Raikhan Maitbassova, Pakhitkanym Ishuova, Dinagul Bayesheva, Nurila Maltabarova, Adyl Katarbayev, Kumisgul Umesheva, Tatyana Marshalkina, Lyazat Manzhuova, Gulnara Abdilova, Gulshat Alimkhanova, Gulmira Yerzhanova, Gulnara Bulabaeva, Nazgul Zhanuzakova, Svetlana Anokhina, Aigul Kuatbayeva, Gulnara Tashenova
Publikováno v:
Mediterranean Journal of Hematology and Infectious Diseases, Vol 14, Iss 1 (2022)
Background and Objectives: Data with more severe mutations of the SARS-CoV-2 virus, compared with the original wild-type strain of COVID-19 disease, were reported worldwide. The study aims to describe the clinical and laboratory manifestations of a m
Externí odkaz:
https://doaj.org/article/f351fa54a39b4ab4980a801cbccbee31
Autor:
Carmen Escuriola Ettingshausen, Vladimír Vdovin, Nadezhda Zozulya, Pavel Svirin, Tatiana Andreeva, Majda Benedik-Dolničar, Victor Jiménez-Yuste, Lidija Kitanovski, Silva Zupancic-Šalek, Anna Pavlova, Angelika Bátorová, Cesar Montaño Mejía, Gulnara Abdilova, Sigurd Knaub, Martina Jansen, Shannely Lowndes, Larisa Belyanskaya, Olaf Walter, Johannes Oldenburg
Publikováno v:
TH Open, Vol 06, Iss 02, Pp e124-e134 (2022)
Background Immune tolerance induction (ITI) with repeated factor VIII (FVIII) administration is the only strategy proven to eradicate inhibitors. The observational ITI study is evaluating ITI with a range of FVIII products. Methods This subgroup anal
Externí odkaz:
https://doaj.org/article/a52b126df9af4fd18ab2a85705afdb71
Autor:
Carmen, Escuriola Ettingshausen, Vladimír, Vdovin, Nadezhda, Zozulya, Pavel, Svirin, Tatiana, Andreeva, Majda, Benedik-Dolničar, Victor, Jiménez-Yuste, Lidija, Kitanovski, Silva, Zupancic-Šalek, Anna, Pavlova, Angelika, Bátorová, Cesar, Montaño Mejía, Gulnara, Abdilova, Sigurd, Knaub, Martina, Jansen, Shannely, Lowndes, Larisa, Belyanskaya, Olaf, Walter, Johannes, Oldenburg
Publikováno v:
TH open : companion journal to thrombosis and haemostasis. 6(2)
Background Immune tolerance induction (ITI) with repeated factor VIII (FVIII) administration is the only strategy proven to eradicate inhibitors. The observational ITI study is evaluating ITI with a range of FVIII products. Methods This subgroup anal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aa2e258334b174cbbd5a342542bc6f59
https://pubmed.ncbi.nlm.nih.gov/35707623
https://pubmed.ncbi.nlm.nih.gov/35707623